This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Nov;35(11):1096-8.

doi: 10.1007/BF02221688.

Immune intervention yes, but for what reason, for whom, when and how?

A Lernmark¹

Affiliations

PMID: 1473622
DOI: 10.1007/BF02221688

Review

Immune intervention yes, but for what reason, for whom, when and how?

A Lernmark. Diabetologia. 1992 Nov.

. 1992 Nov;35(11):1096-8.

doi: 10.1007/BF02221688.

Author

A Lernmark¹

Affiliation

¹ Department of Medicine, University of Washington, Seattle.

PMID: 1473622
DOI: 10.1007/BF02221688

No abstract available

PubMed Disclaimer

Similar articles

Immunotherapy of immune-mediated diabetes. Present and future.
Maclaren N. Maclaren N. Clin Rev Allergy Immunol. 2000 Dec;19(3):277-97. doi: 10.1385/CRIAI:19:3:277. Clin Rev Allergy Immunol. 2000. PMID: 11138410 Review. No abstract available.
World Diabetes Day: Perspectives on immunotherapy of Type 1 Diabetes.
Chatenoud L. Chatenoud L. Eur J Immunol. 2015 Nov;45(11):2968-70. doi: 10.1002/eji.201570114. Eur J Immunol. 2015. PMID: 26645859 No abstract available.
What future for therapeutic prevention of type 1 (insulin-dependent) diabetes mellitus?
Pozzilli P, Signore A, Andreani D. Pozzilli P, et al. Diabetologia. 1992 Nov;35(11):1093-5. doi: 10.1007/BF02221687. Diabetologia. 1992. PMID: 1473621 Review. No abstract available.
New prospects for immunotherapy at diagnosis of type 1 diabetes.
Pozzilli P, Leslie RD. Pozzilli P, et al. Diabetes Metab Res Rev. 2009 May;25(4):299-301. doi: 10.1002/dmrr.970. Diabetes Metab Res Rev. 2009. PMID: 19405079
[The immunotherapy of type-1 diabetes mellitus--experiences, results and prospects].
Manov A. Manov A. Vutr Boles. 1990;29(4):22-7. Vutr Boles. 1990. PMID: 1704164 Review. Bulgarian. No abstract available.

See all similar articles

Cited by

HLA-DRB1 alleles contribute to determining the prognosis of Japanese diabetes mellitus positive for antibodies to glutamate decarboxylase.
Fukui M, Nakano K, Nakamura N, Maruya E, Saji H, Obayashi H, Ohta K, Ohta M, Mori H, Kajiyama S, Wada S, Kida Y, Kosaka K, Deguchi M, Shigeta H, Kitagawa Y, Kondo M. Fukui M, et al. J Clin Immunol. 1998 Jan;18(1):89-92. doi: 10.1023/a:1023248106674. J Clin Immunol. 1998. PMID: 9475358

References

1. Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8337-41 - PubMed
1. J Clin Invest. 1988 Sep;82(3):1123-8 - PubMed
1. Diabetologia. 1991 Jul;34(7):534-5 - PubMed
1. Lancet. 1990 Jan 20;335(8682):147-9 - PubMed
1. N Engl J Med. 1992 Jun 18;326(25):1654-60 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information